BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25390078)

  • 1. Preoperative predictors of pathological lymph node metastasis in patients with renal cell carcinoma undergoing retroperitoneal lymph node dissection.
    Babaian KN; Kim DY; Kenney PA; Wood CG; Wong J; Sanchez C; Fang JE; Gerber JA; Didic A; Wahab A; Golla V; Torres C; Tamboli P; Qiao W; Matin SF; Wood CG; Karam JA
    J Urol; 2015 Apr; 193(4):1101-7. PubMed ID: 25390078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
    Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
    J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.
    Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2004 Aug; 172(2):465-9. PubMed ID: 15247704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy.
    Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
    J Urol; 2008 Jul; 180(1):99-103; discussion 103. PubMed ID: 18485415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis.
    Gershman B; Thompson RH; Boorjian SA; Larcher A; Capitanio U; Montorsi F; Carenzi C; Bertini R; Briganti A; Lohse CM; Cheville JC; Leibovich BC
    J Urol; 2018 May; 199(5):1143-1148. PubMed ID: 29225056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model.
    Gershman B; Takahashi N; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    BJU Int; 2016 Nov; 118(5):742-749. PubMed ID: 26800148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
    Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection.
    Lee HW; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    J Korean Med Sci; 2015 Sep; 30(9):1321-7. PubMed ID: 26339174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?
    Delacroix SE; Chapin BF; Chen JJ; Nogueras-Gonzalez GM; Tamboli P; Matin SF; Wood CG
    J Urol; 2011 Oct; 186(4):1236-41. PubMed ID: 21849197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node dissection should not be dismissed in case of localized renal cell carcinoma in the presence of larger diseases.
    Dell'Oglio P; Larcher A; Muttin F; Di Trapani E; Trevisani F; Ripa F; Carenzi C; Briganti A; Salonia A; Montorsi F; Bertini R; Capitanio U
    Urol Oncol; 2017 Nov; 35(11):662.e9-662.e15. PubMed ID: 28801027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma.
    Russell CM; Lue K; Fisher J; Kassouf W; Schwaab T; Sexton WJ; Tanguay S; Psutka SP; Thompson RH; Leibovich BC; Hanzly MI; Spiess PE; Boorjian SA
    BJU Int; 2016 Jun; 117(6B):E60-6. PubMed ID: 26118331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma.
    Capitanio U; Matloob R; Suardi N; Abdollah F; Castiglione F; Di Trapani D; Russo A; Briganti A; Carenzi C; Salonia A; Montorsi F; Rigatti P; Bertini R
    Urologia; 2012; 79(2):109-15. PubMed ID: 22610843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis.
    Gershman B; Thompson RH; Moreira DM; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    J Urol; 2017 Mar; 197(3 Pt 1):574-579. PubMed ID: 27663461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When to perform lymph node dissection in patients with renal cell carcinoma: a novel approach to the preoperative assessment of risk of lymph node invasion at surgery and of lymph node progression during follow-up.
    Capitanio U; Abdollah F; Matloob R; Suardi N; Castiglione F; Di Trapani E; Capogrosso P; Gallina A; Dell'Oglio P; Briganti A; Salonia A; Montorsi F; Bertini R
    BJU Int; 2013 Jul; 112(2):E59-66. PubMed ID: 23795799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor size and regional lymph node metastasis in patients with M0 renal cell carcinoma: analysis in those having regional lymph node dissection].
    Hashimoto K; Hisasue S; Yanase M; Takahashi A; Hisataki T; Kitamura H; Masumori N; Itoh N; Tsukamoto T
    Hinyokika Kiyo; 2005 Sep; 51(9):621-5. PubMed ID: 16229376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat.
    Mehta V; Mudaliar K; Ghai R; Quek ML; Milner J; Flanigan RC; Picken MM
    Arch Pathol Lab Med; 2013 Nov; 137(11):1584-90. PubMed ID: 23651149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience.
    Hyams ES; Pierorazio P; Proteek O; Sroka M; Kavoussi LR; Allaf ME
    J Urol; 2012 Feb; 187(2):487-92. PubMed ID: 22177913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.